A very nice share price rise last week. I was thinking this...

A very nice share price rise last week. I was thinking this morning, what could have been the catalyst for the steep rise…..?

My first thought last week was institutional buying (Maybe Bombora)

2) In my opinion the market hasn’t given ADI (Ainsoff deterioration index) any value

3) Takeover (Abbott Laboratories Mkt Cap $186B USD)

4) A company taking a strategic stake in Beamtree (Abbott?)

5) NHS future contracts

6) New license agreements with Abbott

ADI will be commercialized in H2 FY23. The way this SaaS is tracking against traditional methods used in hospitals, if this service is proven superior and can save more lives, time and allocate staff accordingly, this alone could be worth hundreds of millions of dollars….

This is an oldie but a goodie..

https://www.9news.com.au/national/n...th-wales/e1b8e92f-3b7b-4171-82f9-612f316dc84c